While not defining lower limits for atherogenic cholesterol goals, for very-high-risk patients with diabetes, the specific lipid targets of non-HDL-C, LDL-C, and apo B, have treatment goals of <100 mg/dL [<2.59 mmol/L], <70 mg/dL [<1.81 mmol/L], and <80 mg/dL [<0.80 g/L], respectively. The gene discussed is APOB; the disease is diabetes mellitus.